| Frank Kennedy, MD | |
|
2435 Ridgegate Row, La Jolla, CA 92037-0919 | |
| (858) 565-0104 | |
| (858) 656-0194 |
| Full Name | Frank Kennedy |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 40 Years |
| Location | 2435 Ridgegate Row, La Jolla, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407957509 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208600000X | Surgery | G57613 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| San Joaquin General Hospital | French camp, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| San Joaquin Faculty Medical Group | 4082631395 | 91 |
| County Of San Joaquin | 6002703436 | 119 |
News Archive
Ductal carcinoma in situ (DCIS), the most common non-invasive lesion of the breast, presents unique challenges for patients and providers largely because the natural course of the untreated disease is not well understood. Because most women diagnosed with DCIS are treated, it is difficult to determine the comparative benefits of different treatment strategies versus active surveillance, meaning systematic followup.
PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the European Commission (EC) approval of Merck & Co., Inc.'s ELONVA®, a long-acting CTP-modified version of the fertility drug follicle stimulating hormone (FSH).
An innovative three-month elective course has helped make some first-year medical students at Albert Einstein College of Medicine more confident about dealing with health disparities they'll likely encounter as physicians, according to a follow-up study published online today in the journal Academic Medicine.
Lumex Instruments' mercury monitor RA-915AM with the new eight sampling line multiplexer was installed at the Hg treatment plant of Minas de Almadén y Arrayanes, S.A., S.M.E (MAYASA).
The Red Cross is responding to a powerful 7.0 magnitude earthquake that struck off the coast of Haiti on Jan. 12, 2010. The earthquake has caused buildings to collapse and wide-spread damage throughout Port au Prince.
› Verified 1 days ago
| Entity Name | County Of San Joaquin |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801830583 PECOS PAC ID: 6002703436 Enrollment ID: O20040301001287 |
News Archive
Ductal carcinoma in situ (DCIS), the most common non-invasive lesion of the breast, presents unique challenges for patients and providers largely because the natural course of the untreated disease is not well understood. Because most women diagnosed with DCIS are treated, it is difficult to determine the comparative benefits of different treatment strategies versus active surveillance, meaning systematic followup.
PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the European Commission (EC) approval of Merck & Co., Inc.'s ELONVA®, a long-acting CTP-modified version of the fertility drug follicle stimulating hormone (FSH).
An innovative three-month elective course has helped make some first-year medical students at Albert Einstein College of Medicine more confident about dealing with health disparities they'll likely encounter as physicians, according to a follow-up study published online today in the journal Academic Medicine.
Lumex Instruments' mercury monitor RA-915AM with the new eight sampling line multiplexer was installed at the Hg treatment plant of Minas de Almadén y Arrayanes, S.A., S.M.E (MAYASA).
The Red Cross is responding to a powerful 7.0 magnitude earthquake that struck off the coast of Haiti on Jan. 12, 2010. The earthquake has caused buildings to collapse and wide-spread damage throughout Port au Prince.
› Verified 1 days ago
| Entity Name | Emergency And Acute Care Medical Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437103942 PECOS PAC ID: 9537108279 Enrollment ID: O20050502000734 |
News Archive
Ductal carcinoma in situ (DCIS), the most common non-invasive lesion of the breast, presents unique challenges for patients and providers largely because the natural course of the untreated disease is not well understood. Because most women diagnosed with DCIS are treated, it is difficult to determine the comparative benefits of different treatment strategies versus active surveillance, meaning systematic followup.
PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the European Commission (EC) approval of Merck & Co., Inc.'s ELONVA®, a long-acting CTP-modified version of the fertility drug follicle stimulating hormone (FSH).
An innovative three-month elective course has helped make some first-year medical students at Albert Einstein College of Medicine more confident about dealing with health disparities they'll likely encounter as physicians, according to a follow-up study published online today in the journal Academic Medicine.
Lumex Instruments' mercury monitor RA-915AM with the new eight sampling line multiplexer was installed at the Hg treatment plant of Minas de Almadén y Arrayanes, S.A., S.M.E (MAYASA).
The Red Cross is responding to a powerful 7.0 magnitude earthquake that struck off the coast of Haiti on Jan. 12, 2010. The earthquake has caused buildings to collapse and wide-spread damage throughout Port au Prince.
› Verified 1 days ago
| Entity Name | San Joaquin Faculty Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225063761 PECOS PAC ID: 4082631395 Enrollment ID: O20051026000742 |
News Archive
Ductal carcinoma in situ (DCIS), the most common non-invasive lesion of the breast, presents unique challenges for patients and providers largely because the natural course of the untreated disease is not well understood. Because most women diagnosed with DCIS are treated, it is difficult to determine the comparative benefits of different treatment strategies versus active surveillance, meaning systematic followup.
PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the European Commission (EC) approval of Merck & Co., Inc.'s ELONVA®, a long-acting CTP-modified version of the fertility drug follicle stimulating hormone (FSH).
An innovative three-month elective course has helped make some first-year medical students at Albert Einstein College of Medicine more confident about dealing with health disparities they'll likely encounter as physicians, according to a follow-up study published online today in the journal Academic Medicine.
Lumex Instruments' mercury monitor RA-915AM with the new eight sampling line multiplexer was installed at the Hg treatment plant of Minas de Almadén y Arrayanes, S.A., S.M.E (MAYASA).
The Red Cross is responding to a powerful 7.0 magnitude earthquake that struck off the coast of Haiti on Jan. 12, 2010. The earthquake has caused buildings to collapse and wide-spread damage throughout Port au Prince.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Frank Kennedy, MD 2435 Ridgegate Row, La Jolla, CA 92037-0919 Ph: (858) 565-0104 | Frank Kennedy, MD 2435 Ridgegate Row, La Jolla, CA 92037-0919 Ph: (858) 565-0104 |
News Archive
Ductal carcinoma in situ (DCIS), the most common non-invasive lesion of the breast, presents unique challenges for patients and providers largely because the natural course of the untreated disease is not well understood. Because most women diagnosed with DCIS are treated, it is difficult to determine the comparative benefits of different treatment strategies versus active surveillance, meaning systematic followup.
PROLOR Biotech, Inc., (OTC Bulletin Board: PBTH) today noted the European Commission (EC) approval of Merck & Co., Inc.'s ELONVA®, a long-acting CTP-modified version of the fertility drug follicle stimulating hormone (FSH).
An innovative three-month elective course has helped make some first-year medical students at Albert Einstein College of Medicine more confident about dealing with health disparities they'll likely encounter as physicians, according to a follow-up study published online today in the journal Academic Medicine.
Lumex Instruments' mercury monitor RA-915AM with the new eight sampling line multiplexer was installed at the Hg treatment plant of Minas de Almadén y Arrayanes, S.A., S.M.E (MAYASA).
The Red Cross is responding to a powerful 7.0 magnitude earthquake that struck off the coast of Haiti on Jan. 12, 2010. The earthquake has caused buildings to collapse and wide-spread damage throughout Port au Prince.
› Verified 1 days ago
Dr. Howard Takiff, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 760 La Canada St, La Jolla, CA 92037 Phone: 949-981-4018 | |
Mahmoud Malas, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9434 Medical Center Dr Fl 1, La Jolla, CA 92037 Phone: 619-543-6980 Fax: 858-657-5033 | |
Cheryl Lorraine Olson, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9850 Genesee Ave, Suite 660, La Jolla, CA 92037 Phone: 858-452-5054 Fax: 858-452-5097 | |
James G. Schwendig, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 9888 Genesee Ave, Lj-601, La Jolla, CA 92037 Phone: 858-626-6350 Fax: 858-626-6354 | |
Angeles Baquerizo, Surgery Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd # 200n, La Jolla, CA 92037 Phone: 858-544-4310 | |
Dr. David Alexander Frankel, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd, La Jolla, CA 92037 Phone: 858-554-8988 | |
Ayemoethu Ma, M.D. Surgery Medicare: Accepting Medicare Assignments Practice Location: 10666 N Torrey Pines Rd # Ms 213, La Jolla, CA 92037 Phone: 858-554-8984 Fax: 858-554-5055 |